✦ LIBER ✦

Complete cure of HBV-HDV co-infection after 24 weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV

✍ Scribed by Joel Gozlan; Karine Lacombe; Elyanne Gault; Gilles Raguin; Pierre-Marie Girard

Book ID: 116651644
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 267 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2008.05.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Case report: Cure of chronic infection w

Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with HIV

✍ Anne Rachline; Pierre Palmer; François Simon; Jean-Michel Molina 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

## Abstract The recommended treatment duration of chronic hepatitis C virus (HCV) in patients infected with human immunodeficiency virus (HIV) is 48 weeks. This report describes a patient co‐infected with HCV genotype 2 and HIV who discontinued HCV therapy after 6 weeks because of adverse events an

The HEP-NET B/C co-infection trial: A pr

The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-α2b and ribavirin in patients with HBV/HCV co-infection

✍ Andrej Potthoff; Heiner Wedemeyer; Wulf O. Boecher; Thomas Berg; Stefan Zeuzem; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 141 KB

853 THE HEP-NET B/C CO-INFECTION TRIAL:

853 THE HEP-NET B/C CO-INFECTION TRIAL: A PROSPECTIVE MULTICENTER STUDY TO INVESTIGATE THE EFFICACY OF PEGYLATED INTERFERON-A2B AND RIBAVIRIN IN PATIENTS WITH HBV/HCV CO-INFECTION

✍ A. Potthoff; H. Wedemeyer; W.O. Boecher; T. Berg; S. Zeuzem; J. Arnold; U. Speng 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Health-related quality of life and sever

✍ Mandorfer, Mattias; Payer, Berit A.; Scheiner, Bernhard; Breitenecker, Florian; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

Emergence of occult minority genotype 2b

Emergence of occult minority genotype 2b hepatitis C infection in an HIV-1-co-infected patient treated for genotype 5a HCV infection with 48 weeks of pegylated-interferon-α 2b and ribavirin

✍ A.J. Buckton; R. Kulasegaram; S.L. Ngui; M. Fisher; R. James; S. Rangarajan; C.G 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 362 KB

547 Mitochondrial effects of a 24-week c

547 Mitochondrial effects of a 24-week course of pegylated-interferon (PEG-IFN) plus ribavirin (RBV) in asymptomatic HCV/HIV CO-infected patients on long-term treatment with didanosine, stavudine or both

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Complete cure of HBV-HDV co-infection after 24&#xa0;weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV

Complete cure of HBV-HDV co-infection after 24 weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV